Mono-Methyl-Histone H3 (K10) Antibody

What is the biological significance of H3K10 monomethylation in epigenetic regulation?

Histone H3 lysine 10 monomethylation (H3K10me1) belongs to the family of histone post-translational modifications that regulate chromatin structure and gene expression. While less extensively characterized than some other histone marks, H3K10 methylation contributes to the histone code that influences DNA accessibility and protein recruitment. Methylation marks on histone proteins coordinate the recruitment of chromatin modifying enzymes containing methyl-lysine binding modules such as chromodomains, PHD fingers, tudor domains, and WD-40 domains . These interactions create a complex regulatory network that influences transcriptional outcomes. Similar to other histone modifications, H3K10me1 likely serves as a docking site for specific reader proteins that mediate downstream biological effects, potentially in transcriptional regulation and chromatin organization.

How does Mono-Methyl-Histone H3 (K10) Antibody specificity compare to antibodies for other histone methylation marks?

Mono-Methyl-Histone H3 (K10) antibody demonstrates high specificity for the monomethylated form of H3K10, with minimal cross-reactivity to unmethylated, dimethylated, or trimethylated forms of the same residue. The specificity of these antibodies is achieved through careful immunogen design and purification procedures. Typically, these antibodies are generated using synthesized peptides derived from human Histone H3 around the mono-methylation site of K10 .

The specificity challenge for histone methylation antibodies generally stems from the similarity of sequences surrounding different lysine residues and the identical chemical nature of methylation at different sites. For example, antibodies targeting H3K4me1 demonstrate preference for low levels of methylation, with binding affinities decreasing significantly with increased methylation states. Studies using isothermal titration calorimetry (ITC) with H3K4me1 antibodies show that compared to monomethylated H3K4, di- and trimethylation decreased binding affinity 2.5- and 14.5-fold, respectively . Similar principles apply to H3K10me1 antibodies, where specificity is paramount to accurately distinguish between various methylation states.

What applications are appropriate for Mono-Methyl-Histone H3 (K10) Antibody in research?

Mono-Methyl-Histone H3 (K10) antibody can be effectively utilized in multiple research applications:

For Western blotting applications, H3K10me1 typically appears at approximately 17 kDa, consistent with the molecular weight of histone H3 . When designing experiments, it's important to note that antibody performance may vary depending on sample preparation methods, particularly with respect to how histones are extracted and processed. Acid extraction methods that preserve histone modifications are typically recommended for optimal results.

What species cross-reactivity can be expected with commercially available Mono-Methyl-Histone H3 (K10) antibodies?

Commercial Mono-Methyl-Histone H3 (K10) antibodies typically demonstrate cross-reactivity with multiple species due to the high conservation of histone H3 sequences across eukaryotes. Based on available information for similar histone antibodies:

What are the methodological differences between detecting H3K10me1 versus other histone H3 methylation marks?

Detection of H3K10me1 versus other histone methylation marks requires careful consideration of several methodological factors:

• Antibody Specificity: The pocket structure of reader domains that recognize different methylation marks varies significantly. For example, the crystal structure of the CW domain of SDG8 reveals that it contains a hydrophobic, narrow pocket that specifically accommodates monomethylated lysine while excluding higher methylation states due to steric hindrance . Similar structural constraints may influence H3K10me1 antibody binding.

• Extraction Protocols: Different histone modifications may show variable stability during extraction procedures. For optimal preservation of methylation marks, acid extraction protocols using H₂SO₄ are commonly employed. One established protocol involves adding 220 μl of 1 M H₂SO₄ to 1 ml mononucleosome-containing supernatant, followed by overnight incubation at 4°C . This approach effectively separates histones from other nuclear proteins while preserving methylation marks.

• Detection Sensitivity: The abundance of different methylation marks varies, affecting detection thresholds. While H3K4me1 is often abundant at enhancer regions, the distribution of H3K10me1 may be more restricted, potentially requiring more sensitive detection methods or enrichment steps.

• Interfering Modifications: Neighboring modifications can interfere with antibody recognition. For accurate detection of H3K10me1, researchers should consider potential interference from modifications at nearby residues such as phosphorylation at S10 or acetylation at K9/K14.

How can mass spectrometry be optimized for accurate quantification of H3K10 monomethylation?

Mass spectrometry (MS) provides a powerful approach for quantifying histone modifications with high precision. For H3K10me1 quantification, several methodological considerations are essential:

What validation strategies should be employed to confirm H3K10me1 antibody specificity in experimental systems?

Rigorous validation of H3K10me1 antibody specificity is crucial for reliable experimental outcomes. Comprehensive validation should include:

• Peptide Competition Assays: Preincubation of the antibody with increasing concentrations of synthetic H3K10me1 peptide should progressively reduce signal in applications like Western blotting or ChIP. Non-competing peptides (e.g., H3K10me0, H3K10me2) should not affect signal intensity.

• Dot Blot Analysis: Testing antibody reactivity against a panel of modified histone peptides can reveal potential cross-reactivity. This should include H3K10 with different methylation states, as well as similar modifications on other lysine residues.

• Genetic Validation: In systems where methyltransferases or demethylases for H3K10 are known, genetic depletion or overexpression of these enzymes should result in predictable changes in signal intensity.

• Mass Spectrometry Correlation: Antibody-based detection methods should be correlated with mass spectrometry-based quantification of H3K10me1 levels. MS-based approaches can provide independent verification of modification status.

• Single Substitution Peptide Arrays: Testing against peptides with single amino acid substitutions around the K10 position can identify crucial epitope requirements and potential interference from neighboring modifications.

By implementing these validation strategies, researchers can establish high confidence in the specificity of H3K10me1 antibodies for their particular experimental conditions.

What are the optimal extraction protocols for preserving H3K10 monomethylation in different sample types?

Preservation of histone modifications, including H3K10 monomethylation, requires careful extraction protocols tailored to sample type:

For cell culture samples:

• Harvest cells (approximately 1 × 10⁹ cells per replicate for comprehensive analysis)

• Resuspend cell pellet in permeabilization buffer

• Add digitonin to 40 μM final concentration and lyse cells at room temperature for 15 minutes with gentle rotation

• Wash the pellet three times in isotonic buffer (100 mM KCl, 10 mM Tris 8.0, 10 mM CaCl₂, 5% Glycerol, 1 mM DTT, with protease inhibitors and deacetylase inhibitors like 50 mM sodium butyrate)

• For nucleosome preparation, digest with 2.5 U MNase for 15 minutes at 25°C

• For acid extraction of histones, add 220 μl of 1 M H₂SO₄ to 1 ml mononucleosome-containing supernatant and incubate overnight at 4°C

• Remove acid-insoluble proteins by centrifugation at 4°C and 16,000 × g for 10 minutes

• Concentrate histones using StrataClean® resin or similar methods

For tissue samples:

• Pulverize tissue under liquid nitrogen

• Homogenize in nuclear isolation buffer with protease and phosphatase inhibitors

• Filter through 100 μm mesh to remove debris

• Continue with acid extraction as described for cell samples

These protocols maintain the integrity of histone modifications by rapidly inactivating enzymatic activities that could alter modification patterns post-extraction.

How can ChIP-seq experiments be optimized for Mono-Methyl-Histone H3 (K10) antibody applications?

Optimizing ChIP-seq experiments for H3K10me1 requires careful consideration of several parameters:

• Crosslinking Conditions: Standard formaldehyde crosslinking (1% for 10 minutes at room temperature) is generally effective, but optimization may be required. Excessive crosslinking can mask epitopes, while insufficient crosslinking may fail to capture transient interactions.

• Sonication Parameters: Chromatin should be sheared to fragments of 200-500 bp for optimal resolution. Over-sonication can damage epitopes, while under-sonication reduces IP efficiency and genomic resolution.

• Antibody Amount: Titration experiments should be performed to determine the optimal antibody-to-chromatin ratio. For histone modifications, typically 2-5 μg of antibody per 25-50 μg of chromatin provides good results, but this should be empirically determined.

• Wash Stringency: Sequential washes with increasing salt concentration help reduce non-specific binding. Typical protocols use low salt (150 mM NaCl), high salt (500 mM NaCl), LiCl (250 mM), and TE buffer washes.

• Controls: Include input chromatin, IgG negative controls, and spike-in normalization controls (e.g., Drosophila chromatin with Drosophila-specific antibody) for accurate quantification and comparison across samples.

• Library Preparation: Use library preparation methods that preserve the typically limited amount of ChIP DNA. PCR cycles should be minimized to prevent amplification bias.

• Data Analysis: Peak calling algorithms should be tuned for the expected distribution pattern of H3K10me1. Broader peaks may require different parameters than sharp, punctate peaks.

By systematically optimizing these parameters, researchers can achieve high-quality ChIP-seq data for H3K10me1 genomic distribution analysis.

What are the key considerations for troubleshooting weak signals in H3K10me1 Western blotting?

When encountering weak signals in Western blotting for H3K10me1, several troubleshooting strategies should be considered:

• Sample Preparation:

  • Ensure complete lysis and histone extraction using recommended acid extraction protocols

  • Verify protein concentration using reliable methods specific for histones

  • Add deacetylase inhibitors (e.g., sodium butyrate, 50 mM) and phosphatase inhibitors to buffers

• Gel Running Conditions:

  • Use appropriate gel concentration (15-18% for histones)

  • Consider specialized gel systems like NuPAGE Novex 4-12% Bis-Tris gels

  • Run at lower voltage to improve resolution of closely migrating bands

• Transfer Optimization:

  • Use PVDF membranes rather than nitrocellulose for better protein retention

  • Optimize transfer conditions (wet transfer at 30V overnight often works better than rapid transfers)

  • Consider adding SDS (0.1%) to transfer buffer to improve transfer of basic proteins

• Antibody Conditions:

  • Try different dilutions; recommended ranges are typically 1:500-1:2000

  • Extend primary antibody incubation time (overnight at 4°C)

  • Use 5% BSA rather than milk for blocking and antibody dilution

• Detection Enhancement:

  • Use high-sensitivity ECL substrates

  • Consider signal amplification systems

  • Extend exposure times, but watch for increased background

• Verification Steps:

  • Stain the membrane post-transfer to confirm efficient transfer

  • Use total H3 antibody on parallel samples to confirm successful extraction

  • Include positive controls (cell lines known to express H3K10me1)

By systematically addressing these factors, most weak signal issues in H3K10me1 Western blotting can be resolved.

How do different fixation methods affect the detection of H3K10 monomethylation in immunofluorescence applications?

Fixation methods significantly impact the detection of histone modifications in immunofluorescence experiments. For H3K10me1, consider the following fixation approaches:

• Paraformaldehyde Fixation: Standard 4% PFA fixation for 10-15 minutes preserves most histone modifications but may not provide optimal nuclear permeability.

• Methanol Fixation: Ice-cold methanol fixation (10 minutes at -20°C) provides excellent nuclear permeabilization but can extract some nuclear proteins and potentially alter epitope accessibility.

• Combined PFA-Methanol: Sequential fixation with 4% PFA followed by methanol often provides superior results for histone modifications, combining structural preservation with good permeabilization.

• Specialized Fixatives: Periodate-lysine-paraformaldehyde (PLP) fixative can preserve certain fragile epitopes better than standard fixatives.

For optimal results with H3K10me1 antibodies in immunofluorescence applications, a recommended approach includes:

• Initial fixation with 4% PFA (10 minutes at room temperature)

• Permeabilization with 0.2% Triton X-100 (10 minutes)

• Additional permeabilization with ice-cold methanol (5 minutes at -20°C)

• Extended blocking (1-2 hours) with 3-5% BSA to reduce background

• Primary antibody incubation at 1:200 dilution overnight at 4°C

This optimized protocol helps balance epitope preservation with accessibility for antibody binding.

What are the current methodological approaches for studying the dynamics of H3K10 monomethylation in living cells?

Studying histone modification dynamics in living cells presents significant challenges but offers valuable insights into temporal regulation. Current approaches include:

• Fluorescent Antibody-Based Sensors: Modified antibody fragments (Fabs) against H3K10me1 can be labeled with fluorescent dyes and introduced into living cells through microinjection or cell-penetrating peptides. Changes in localization patterns can be monitored in real-time using confocal microscopy.

• FRET-Based Biosensors: Engineered biosensors containing methyl-lysine binding domains fused to fluorescent proteins can detect changes in H3K10me1 levels through Förster resonance energy transfer (FRET). These sensors can be stably expressed in cells for longitudinal studies.

• Targeted Mass Spectrometry: SNAP-tag approaches allow pulse-chase labeling of histone proteins, which can be combined with targeted mass spectrometry to quantify modification changes over time.

• Microfluidic Approaches: Microfluidic devices coupled with fluorescence microscopy allow precise control of the cellular environment while monitoring histone modification changes in response to various stimuli.

• Optogenetic Manipulation: Photactivatable methyltransferases or demethylases can be used to induce local changes in H3K10 methylation status, allowing studies of downstream effects with spatial and temporal precision.